Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Diurnal Group Plc
Life Sciences
Ready to press the button
By
Dr Martin Hall
14 Sep 2017
ValiRx
Life Sciences
GeneICE and VAL101 progress
13 Sep 2017
1pm Plc
Financials
Initiation: Financing powerhouse: A lunchtime treat
By
Mark Thomas
12 Sep 2017
Oxford BioMedica
Life Sciences
New era for cell and gene therapies
12 Sep 2017
Agriculture
The Tropical Tree Crop Sector of Sub-Saharan Africa
By
Yingheng Chen
01 Sep 2017
Oxford BioMedica
Life Sciences
Ready for CTL019 approval
24 Aug 2017
Non-Standard Finance
Financials
H117 Delivering multiple growth options
By
Mark Thomas
11 Aug 2017
Tissue Regenix
Life Sciences
CellRight: Transforming US growth prospects
10 Aug 2017
Burford Capital
Financials
Another record set of results
By
Dr Brian Moretta
01 Aug 2017
Arbuthnot Banking Group Plc
Financials
Strong, profitable, growth not shown in share price
By
Mark Thomas
27 Jul 2017
Collagen Solutions Plc
Life Sciences
Transitioning to accelerated sustainable growth
By
Dr Martin Hall
25 Jul 2017
Prev
1
...
78
79
80
81
82
...
84
Next
